Trajan Scientific and Medical acquires chromatography and liquid handling business areas of SGE Analytical Science
Trajan Scientific and Medical (Victoria, Australia) has completed the acquisition of the chromatography and liquid handling businesses of SGE Analytical Science (Ringwood, Victoria, Australia).
Trajan Scientific and Medical (Victoria, Australia) has completed the acquisition of the chromatography and liquid handling businesses of SGE Analytical Science (Ringwood, Victoria, Australia).
SGE was founded in 1961 in Australia by Ern Dawes, and has remained within the Dawes family for over 50 years. The business has grown to 300 staff worldwide, with manufacturing operations in Ringwood, Australia, and subsidiary offices in the USA, Europe, and Japan. Under the terms of the agreement, Trajan has acquired these sites along with all shareholdings.
“Trajan’s goal is to bring together a group of leading companies with a common focus in the areas of biological, environmental, and food analysis. SGE is an ideal platform for Trajan, with a global footprint and a depth of capability and infrastructure, servicing the leading companies in analytical science” said Stephen Tomisich, CEO of Trajan.
For more information, please visit:
www.trajanscimed.com
This story originally appeared in The Column. Click here to view that issue.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
